FDA DrugClass IINotable

FDA Recall: IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactur

Date: 2026-07-08
Brand: ACCORD BIOPHARMA INC
Category: Drug
FDA Class: Class II

Description

Lack of assurance of Sterility:

Hazard

Lack of assurance of Sterility:

Remedy

326 vials

Related Recalls